5/9
12:11 pm
holx
Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Argus from $89.00 to $95.00. They now have a "buy" rating on the stock.
Low
Report
Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Argus from $89.00 to $95.00. They now have a "buy" rating on the stock.
5/8
07:34 am
holx
$2.75+ Epigenetic Markets - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2019-2023 & 2024-2029F [Yahoo! Finance]
Low
Report
$2.75+ Epigenetic Markets - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2019-2023 & 2024-2029F [Yahoo! Finance]
5/7
01:10 pm
holx
A Dive into Hologic (HOLX) International Revenue Trends and Forecasts [Yahoo! Finance]
Low
Report
A Dive into Hologic (HOLX) International Revenue Trends and Forecasts [Yahoo! Finance]
5/3
11:32 pm
holx
Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
5/3
05:08 pm
holx
Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at JPMorgan Chase & Co. from $85.00 to $91.00. They now have an "overweight" rating on the stock.
Low
Report
Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at JPMorgan Chase & Co. from $85.00 to $91.00. They now have an "overweight" rating on the stock.
5/3
02:04 pm
holx
Hologic's (HOLX) Q2 Earnings Beat Estimates, 2024 View Up [Yahoo! Finance]
Low
Report
Hologic's (HOLX) Q2 Earnings Beat Estimates, 2024 View Up [Yahoo! Finance]
5/3
12:53 pm
holx
Hologic, Inc. (NASDAQ:HOLX) Q2 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Hologic, Inc. (NASDAQ:HOLX) Q2 2024 Earnings Call Transcript [Yahoo! Finance]
5/3
08:08 am
holx
Hologic, Inc. (NASDAQ: HOLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
Low
Report
Hologic, Inc. (NASDAQ: HOLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
5/2/2024
04:01 pm
holx
hologic, inc.
BEAT
Report
0.8%
hologic, inc.
2/1/2024
04:01 pm
holx
hologic, inc.
BEAT
Report
-2.6%
hologic, inc.
11/9/2023
04:01 pm
holx
hologic, inc.
MISS
Report
7.3%
hologic, inc.
7/31/2023
04:01 pm
holx
hologic, inc.
BEAT
Report
-3.5%
hologic, inc.
5/3
08:01 am
holx
Form 8-K/A HOLOGIC INC For: May 02
Low
Report
Form 8-K/A HOLOGIC INC For: May 02
5/3
07:46 am
holx
Form 10-Q HOLOGIC INC For: Mar 30
Low
Report
Form 10-Q HOLOGIC INC For: Mar 30
5/2
04:02 pm
holx
Form 8-K HOLOGIC INC For: May 02
Low
Report
Form 8-K HOLOGIC INC For: May 02
4/23
04:31 pm
holx
Form 4 HOLOGIC INC For: Apr 19 Filed by: MACMILLAN STEPHEN P
Low
Report
Form 4 HOLOGIC INC For: Apr 19 Filed by: MACMILLAN STEPHEN P
3/15
04:13 pm
holx
Form 4 HOLOGIC INC For: Mar 14 Filed by: GARRETT SCOTT T
Low
Report
Form 4 HOLOGIC INC For: Mar 14 Filed by: GARRETT SCOTT T
3/14
09:54 am
holx
Form 144 HOLOGIC INC Filed by: GARRETT SCOTT T
Neutral
Report
Form 144 HOLOGIC INC Filed by: GARRETT SCOTT T
3/12
04:21 pm
holx
Form 8-K HOLOGIC INC For: Mar 07
Low
Report
Form 8-K HOLOGIC INC For: Mar 07
3/11
06:45 pm
holx
Form 4 HOLOGIC INC For: Mar 07 Filed by: Dockendorff Charles J
Low
Report
Form 4 HOLOGIC INC For: Mar 07 Filed by: Dockendorff Charles J
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
3/19
CDC, public labs have conducted 37,824 COVID-19 tests [MarketWatch]
6.5%
3/18
CDC, public health labs have conducted at least 31,000 tests [MarketWatch]
5.8%
4/23
Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating.
5.1%
4/2
Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Needham & Company LLC from $62.00 to $52.00. They now have a "buy" rating on the stock.
4.8%
4/8
Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at William Blair.
4.7%
11/20
Clayton, Dubilier & Rice to Acquire Market-Leading Medical Aesthetics Technology Company
4.3%
3/9
Form 4 HOLOGIC INC For: Mar 05 Filed by: HANTSON LUDWIG
4.0%
4/7
Form 8-K HOLOGIC INC For: Apr 07
2.9%
3/26
Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Barclays PLC from $51.00 to $43.00. They now have an "equal weight" rating on the stock.
2.8%
1/31
Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at TheStreet from a "c" rating to a "b+" rating.
2.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register